Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-02-25

Clinical Trial Update: Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - III [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating left atrial appendage closure in patients with atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Atrial Fibrillation | Phase 4 | Status: WITHDRAWN